Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Amanda Rachel Gladwin has worked on the following 42 EPO patent applications which have been published in the last five years:

EP11776738

POLYMORPHS AND SALTS OF 6-(1H-INDOL-4-YL)-4-(5- { [4-(1-METHYLETHYL)-1-PI PERAZINYL]METHYL} -1,3-OXAZOL-2-YL)-1H-INDAZOLE AS PI3K INHIBITORS FOR USE IN THE TREATMENT OF E.G. RESPIRATORY DISORDERS

IPC classification:
A61K 31/422, A61P 11/00, A61P 31/12, A61P 35/00, A61P 37/00, C07D 413/14
Applicant:
Glaxo Group Limited
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP12715280

THIOAMIDE, AMIDOXIME AND AMIDRAZONE DERIVATIVES AS HIV ATTACHMENT INHIBITORS

IPC classification:
A61K 31/496, A61P 31/18, C07D 209/18, C07D 471/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
PATENT GRANTED
EP12814906

AZAINDOLE COMPOUNDS AND METHODS FOR TREATING HIV

IPC classification:
A01N 43/42, A61K 31/44
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
PATENT GRANTED
EP12740119

COMPOSITION

IPC classification:
A61K 9/00, A61K 31/522, A61P 11/06, A61P 37/08
Applicant:
GlaxoSmithKline LLC
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP12766361

SPIRO BICYCLIC DIAMINE DERIVATIVES AS HIV ATTACHMENT INHIBITORS

IPC classification:
A61K 31/437, A61P 31/18, C07D 519/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
PATENT GRANTED
EP12766362

FUSED BICYCLIC DIAMINE DERIVATIVES AS HIV ATTACHMENT INHIBITORS

IPC classification:
A61K 31/437, A61P 31/18, C07D 519/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Annabel Rose Beacham, Dehns Ltd
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
PATENT GRANTED
EP12833476

PYRROLOPYRIDINONE COMPOUNDS AND METHODS FOR TREATING HIV

IPC classification:
A01N 43/90
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
PATENT GRANTED
EP12809969

CO-PROCESSING METHOD AND FORMULATION FOR HIV ATTACHMENT INHIBITOR PRODRUG COMPOUND AND EXCIPIENTS

IPC classification:
A61K 9/14, A61K 9/20
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP13705076

METHODS FOR THE PREPARATION OF HIV ATTACHMENT INHIBITOR PIPERAZINE PRODRUG COMPOUND

IPC classification:
C07D 471/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
GRANT OF PATENT INTENDED
EP12806889

VOLTAGE-GATED SODIUM CHANNEL BLOCKERS

IPC classification:
A61K 31/497, A61P 11/14, C07D 401/14, C07D 405/14
Applicant:
Glaxo Group Limited
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13744796

COMPOUNDS AND METHODS FOR TREATING HIV

IPC classification:
A61K 31/437, A61P 31/18, C07D 471/04, C07D 471/08, C07D 471/14, C07D 491/10
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
The patent has been granted
EP13756249

PYRAZOLOPYRIMIDINE COMPOUNDS

IPC classification:
A61K 31/519, A61P 37/00, C07D 487/04
Applicant:
GlaxoSmithKline LLC
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
The patent has been granted
EP13748452

PIPERIDINE AMIDE DERIVATIVES AS HIV ATTACHMENT INHIBITORS

IPC classification:
A61K 31/437, A61K 31/454, A61P 31/18, C07D 401/06, C07D 471/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP13753225

TRICYCLIC AMIDINE DERIVATIVES AS HIV ATTACHMENT INHIBITORS

IPC classification:
A61K 31/551, A61K 31/553, A61P 31/18, C07D 403/12, C07D 413/12, C07D 471/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP13748451

TRICYCLIC ALKENE DERIVATIVES AS HIV ATTACHMENT INHIBITORS

IPC classification:
A61K 31/437, A61K 31/454, A61K 31/4545, A61P 31/18, C07D 401/06, C07D 401/14, C07D 471/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP14194866

OXAZOLE SUBSTITUTED INDAZOLES AS PI3-KINASE INHIBITORS

IPC classification:
A61K 31/497, A61K 31/535, A61P 11/00, A61P 31/12, A61P 35/00, A61P 37/00, C07D 413/14
Applicant:
Glaxo Group Limited
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP13857477

NOVEL COMPOUNDS

IPC classification:
A61K 31/519
Applicant:
GlaxoSmithKline LLC
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
The patent has been granted
EP13856110

NOVEL COMPOUNDS

IPC classification:
A61K 31/519
Applicant:
GlaxoSmithKline LLC
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
PATENT GRANTED
EP13857520

NOVEL COMPOUNDS

IPC classification:
A61K 31/519
Applicant:
GlaxoSmithKline LLC
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
The patent has been granted
EP15164931

ANTIVIRAL THERAPY

IPC classification:
A61K 31/4985, A61K 31/513, A61K 31/52, A61K 31/536, A61P 31/18
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP15180409

COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES

IPC classification:
A61K 31/427, A61K 31/4402, A61K 31/472, A61K 31/4725, A61K 31/496, A61K 31/506, A61P 31/18, C07D 471/04, C07D 487/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
The patent has been granted
EP14722482

2-KETO AMIDE DERIVATIVES AS HIV ATTACHMENT INHIBITORS

IPC classification:
A61K 31/404, C07D 401/06, C07D 471/04, C07D 519/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP11715752

COMBINATION THERAPY COMPRISING A CCR5 ANTAGONIST, A HIV-1 PROTEASE INHIBITOR AND A PHARMACOKINETIC ENHANCER

IPC classification:
A61K 31/00, A61K 31/351, A61K 31/4178, A61K 31/427, A61K 31/4402, A61K 31/4433, A61K 31/4545, A61K 31/46, A61K 31/472, A61K 31/4725, A61K 31/496, A61K 31/499, A61K 31/506, A61K 45/06, A61P 31/18
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15170143

PURINE DERIVATIVES FOR USE IN THE TREATMENT OF ALLERGIC, INFLAMMATORY AND INFECTIOUS DISEASES

IPC classification:
A61K 31/522, A61P 35/00, A61P 37/00, C07D 473/16, C07D 473/18
Applicant:
GlaxoSmithKline LLC
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP11785122

INHIBITORS OF HIV REPLICATION

IPC classification:
A61K 31/4365, A61K 31/506, A61K 45/06, C07D 495/04, C07D 495/14
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
PATENT GRANTED
EP11760040

PROCESS FOR PREPARING CARBAMOYLPYRIDONE DERIVATIVES AND INTERMEDIATES

IPC classification:
A01N 43/42, A61K 31/44, C07D 213/68, C07D 213/80, C07D 498/14
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
PATENT GRANTED
EP11737484

Therapeutic combination comprising dolutegravir, abacavir and lamivudine

IPC classification:
A61K 31/4985, A61K 31/513, A61K 31/52, A61K 31/536, A61K 38/55, A61P 31/18
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
PATENT REVOKED
EP11796876

ALKYL AMIDES AS HIV ATTACHMENT INHIBITORS

IPC classification:
A61K 31/437, A61P 31/18, C07D 471/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11755311

POLYMORPHS AND SALTS OF N-[5-[4-(5-{[(2R,6S)-2,6-DIMETHYL-4-MORPHOLINYL]METHYL}-& xA;1,3-OXAZOL-2-YL)-1H-INDAZOL-6-YL]-2-(METHYLOXY)-3-PYRIDINYL]METHANESULFONAMIDE

IPC classification:
A61K 31/422, A61P 11/00, C07D 413/14
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14790034

PI3K INHIBITOR FOR TREATMENT OF RESPIRATORY DISEASE

IPC classification:
A61K 31/497, A61K 31/553, A61P 11/00
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP14790537

PI3K INHIBITOR FOR TREATMENT OF RESPIRATORY DISEASE

IPC classification:
A61K 31/497, A61K 31/553, A61P 11/00
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP11755310

INDAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF INFLUENZA VIRUS INFECTION

IPC classification:
A61K 31/416, A61K 31/422, A61K 31/4245, A61K 31/427, A61K 31/437, A61K 31/4439, A61K 31/454, A61K 31/496, A61K 31/5377, A61K 31/5386, A61P 31/16
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
PATENT GRANTED
EP13156120

Quinoline derivatives as PI3 kinase inhibitors

IPC classification:
A61K 31/47, C07D 285/24, C07D 401/04, C07D 401/14, C07D 413/14, C07D 417/14, C07D 471/04, C07D 487/04, C07D 495/04, C07D 498/04
Applicant:
GlaxoSmithKline
Applicant:
GlaxoSmithKline LLC
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11814690

PROCESS FOR PREPARING COMPOUND HAVING HIV INTEGRASE INHIBITORY ACTIVITY

IPC classification:
C07D 211/94, C07D 213/80, C07D 498/14
Applicant:
Shionogi & Co. Limited (Shionogi Seiyaku Kabushiki-gaisha)
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
PATENT GRANTED
EP15706413

PYRROLO[3,2]PYRIMIDINE DERIVATIVES AS INDUCERS OF HUMAN INTERFERON

IPC classification:
A61K 31/519, A61P 29/00, A61P 35/00, A61P 37/00, C07D 487/04
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
The patent has been granted
EP16187411

ANTIVIRAL THERAPY

IPC classification:
A61K 31/52, A61K 31/5365, A61P 31/18
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP15742106

ISOINDOLINE DERIVATIVES FOR USE IN THE TREATMENT OF A VIRAL INFECTION

IPC classification:
A61K 31/4035, A61K 31/454, C07D 209/44, C07D 401/06, C07D 407/06, C07D 407/10
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15741368

ISOINDOLINONE DERIVATIVES USEFUL AS ANTIVIRAL AGENTS

IPC classification:
A61K 31/4035, A61P 31/18, C07D 209/46, C07D 405/04, C07D 413/04
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15741363

PHENYL AND TERTBUTYLACETIC ACID SUBSTITUTED PYRIDINONES HAVING ANTI-HIV EFFECTS

IPC classification:
A61K 31/4418, A61K 31/4439, A61P 31/18, C07D 213/64, C07D 213/75, C07D 213/81
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15770489

TREATMENT OF RESPIRATORY CONDITIONS WITH NOTCH INHIBITORS

IPC classification:
A61K 31/00, A61K 31/5513, A61K 39/395
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
Request for examination was made
EP15820021

A PROCESS FOR PREPARING HALOGENATED AZAINDOLE COMPOUNDS USING BOROXINE

IPC classification:
A61K 31/437, A61P 31/18, C07D 471/04, C07F 9/09
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
Request for examination was made
EP16700303

PHARMACEUTICAL COMBINATION

IPC classification:
A61K 9/00, A61K 31/4709, A61K 31/58, A61P 11/08
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
Request for examination was made

Please Sign in to use this feature